| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Bva12g02185 | ATGAGTGCGGATTTAAAGACAACTGCCCCTAACGGTCGTGAGAACGTTTTAACATCACAGGAGGAACAGGCAAAGGTGAATGAGGTTAGAAGGTTGATAGGGCCGTTGCCAGATAAGTCATCCATTTATTGTTCTGATGCATCCATCACACGGTATTTAATAGCACGGAATTGGAATGTCAAGAAAGCTACTAAAATGTTGAAAGAGACCGTAAAATGGAGAGCAGAATATAAACCTGAAGAGATCCGTTGGGAAGATATTGCTCACGAAGCAGAGACAGGGAAGATCTATAGATCAAATTATATTGACAAGCATGGCAGAACAGTCCTTGTAATGAGACCTTCGCGTCagAACTCAAAGTCCATAAAAGGACAGATTAAGTATTTGGTATACTGTATGGAGAACGCTATTTTAAATCTTCCGCCAGATCAGGGAAAGATGGTCTGGTTAATTGACTTCCAGGGTTTCAATTTGTCGCATATATCGGTAAAGGTGACGCGAGAAACTGCCCATGTATTACAAAACCATTATCCAGAACGGCTGGGTTTGGCAATACTGTACAATCCACCAAAGTTCTTTGAACCATTCTTCACGATGGTGAAGCCCCTGTTAGAGCCCAAGACCTATAATAAAGTCAAGTTCGTTTATTCTGATGATCTCAACAGCAAGAAGATCATGGAGGATCTGTTTGATTCTGACCAACTTGAGTCTGGATTTGGTGGGAATGACGACACAGGATTTGACATAAGTAAATATGCTGAGAGAATGAAAGAGGATGATAAGAAGATACCCTCGTTTTGGACTAGGTTGAACTCTTCATCGGCAGCCCCACATGATGCTCCTCCTTTAGATTCAATCAAGATAAACTCTGATTCTGATGCTTCCGACAATGAGGAAAAAGATCTCTCTCCTGCTCATGGGATGGATGCGGAGATTATAAATACTGATCAGATGGTCAATCAAGGGGACCGAAATGACACAGCAGATAGACATTA | 995 | 0.4151 | MSADLKTTAPNGRENVLTSQEEQAKVNEVRRLIGPLPDKSSIYCSDASITRYLIARNWNVKKATKMLKETVKWRAEYKPEEIRWEDIAHEAETGKIYRSNYIDKHGRTVLVMRPSRQNSKSIKGQIKYLVYCMENAILNLPPDQGKMVWLIDFQGFNLSHISVKVTRETAHVLQNHYPERLGLAILYNPPKFFEPFFTMVKPLLEPKTYNKVKFVYSDDLNSKKIMEDLFDSDQLESGFGGNDDTGFDISKYAERMKEDDKKIPSFWTRLNSSSAAPHDAPPLDSIKINSDSDASDNEEKDLSPAHGMDAEIINTDQMVNQGDRNDTADRH | 331 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Bva12g02185 | 331 | Pfam | CRAL/TRIO domain | 93 | 241 | IPR001251 | - | |
| Bva12g02185 | 331 | MobiDBLite | consensus disorder prediction | 291 | 306 | - | - | |
| Bva12g02185 | 331 | Pfam | CRAL/TRIO, N-terminal domain | 45 | 69 | IPR011074 | - | |
| Bva12g02185 | 331 | ProSiteProfiles | CRAL-TRIO lipid binding domain profile. | 84 | 247 | IPR001251 | - | |
| Bva12g02185 | 331 | PANTHER | GH16843P | 1 | 303 | - | - | |
| Bva12g02185 | 331 | SUPERFAMILY | CRAL/TRIO domain | 84 | 262 | IPR036865 | - | |
| Bva12g02185 | 331 | SMART | CRAL_TRIO_N_2 | 45 | 70 | IPR011074 | - | |
| Bva12g02185 | 331 | CDD | SEC14 | 92 | 242 | IPR001251 | - | |
| Bva12g02185 | 331 | SMART | sec14_4 | 90 | 244 | IPR001251 | - | |
| Bva12g02185 | 331 | MobiDBLite | consensus disorder prediction | 271 | 331 | - | - | |
| Bva12g02185 | 331 | SUPERFAMILY | CRAL/TRIO N-terminal domain | 18 | 86 | IPR036273 | - | |
| Bva12g02185 | 331 | PANTHER | CRAL-TRIO LIPID BINDING DOMAIN, CRAL/TRIO DOMAIN-CONTAINING PROTEIN-RELATED | 1 | 303 | - | - | |
| Bva12g02185 | 331 | Gene3D | - | 3 | 274 | IPR036865 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Bva12g02185 | Bva-Chr12 | 16849451 | 16853321 | Dispersed/Wgd |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Bva12g02185 | - | - | gmx:100780151 | 519.62 |
| Select | Gene_1 | Chr_1 | Start_1 | End_1 | Gene_2 | Chr_2 | Start_2 | End_2 | Event_name |
|---|---|---|---|---|---|---|---|---|---|
| Bva12g02185 | 12 | 16849451 | 16853321 | Bva06g02746 | 06 | 17275480 | 17281370 | BWGD | |
| Bva12g02185 | 12 | 16849451 | 16853321 | Bva12g02185 | 12 | 16849451 | 16853321 | ECH |